Immungenetics AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 2009-08-18
- Employees
- 11
- Market Cap
- -
- Website
- http://immungenetics.com
Clinical Trials
3
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Immungenetics AG
- Target Recruit Count
- 20
- Registration Number
- NCT03417986
- Locations
- 🇩🇪
Klinik für Psychiatrie und Psychotherapie Universitätsmedizin Göttingen, Göttingen, Germany
🇩🇪Zentralinstitut für seelische Gesundheit, Medizinische Fakultät Mannheim, Universität Heidelberg,, Mannheim, Germany
News
No news found